Singapore markets closed

Aeterna Zentaris Inc. (AEZS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
7.79+0.08 (+1.04%)
At close: 04:00PM EDT
7.68 -0.05 (-0.65%)
Pre-market: 07:59AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close7.71
Open7.95
Bid7.72 x 100
Ask9.98 x 200
Day's range7.52 - 7.95
52-week range5.44 - 12.80
Volume5,051
Avg. volume9,517
Market cap24.108M
Beta (5Y monthly)2.07
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Aeterna Zentaris and Ceapro Complete Merger Transaction

    TORONTO and EDMONTON, Alberta, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF) (“Ceapro”), two innovative biopharmaceutical development companies, are pleased to announce the successful completion and closing of their all-stock merger of equals transaction (the “Transaction”), which was previously announced by Aeterna and Ceapro in their joint press release of December 14, 2023. “This is a

  • GlobeNewswire

    Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date

    TORONTO, ONTARIO, May 29, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that it is making an application for an order pursuant to section 133(3) of the Canada Business Corporations Act extending the time for the Company to call and hold its annual meeting of its shareholders to a date that

  • GlobeNewswire

    Aeterna Zentaris Announces Details Regarding Transaction with Ceapro

    TORONTO, ON, May 17, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) announces that it has finalized certain details regarding the previously announced merger of equals transaction (the “Transaction”) with Ceapro Inc. (“Ceapro”). On May 3, 2024, the Company completed a share consolidation (or reverse stock split) (the “Consolidation”) of its common shares (the “Common Shares”) on the basis of one post-Consolidation Common Share for every fou